Abbott, a global healthcare leader founded in 1888, has been dedicated to unlocking the human potential since its inception. Today, our 114,000 passionate colleagues are making a lasting impact on people’s health in more than 160 countries worldwide.

By developing life-changing technologies in diagnostics, medical devices, nutritionals and branded generic medicines, we empower people to live better, healthier lives at every stage.

For over 60 years, we have proudly contributed to the Kingdom’s healthcare sector, establishing a strategic partnership with the Ministry of Health to support the nation’s health objectives.

In addition to Abbott’s three offices in Riyadh, Jeddah and Dammam, we inaugurated a Regional Headquarters in Riyadh in 2023. Today, over 400 dedicated colleagues work to enhance the well-being of individuals through the power of health.

Our commitment to local manufacturing with various partners allows us to be closer to the communities we serve, while contributing to the local economy and sharing our manufacturing expertise and quality standards with our partners.

Our caring extends not only to those we serve but also to our own employees. This commitment has earned us recognition as one of the best companies to work for, securing the Top Employer award in Saudi Arabia for three consecutive years.

Amgen is one of the world's leading biotechnology companies, present in more than 100 countries and with a global team of 23,000 employees.

With a 40-year history, the company was created to unlock scientific knowledge about biology and drive significant advances in health. That founding principle identifies us as a company strongly grounded in science and focused on substantially improving the quality of life for patients with serious illnesses around the world.

Amgen was one of the pioneering companies in the use of living cells to manufacture biological medicines, opening the way to the field of biotechnology: we created and gave visibility to the scientific and productive procedures that turned biotechnology into a source of therapies for patients. At Amgen we develop innovative medicines for significant unmet medical needs focused on several therapeutic areas: oncology, hematology, bone health, inflammation, cardiovascular disease, neurology, and nephrology.

We have a robust portfolio of innovative medicines, and important projects underway, to lead the next generation in bio-manufacturing. Our research focuses on the study of innovative molecules, new indications for various drugs and biosimilar treatments.

Amgen in Saudi Arabia

Amgen has been operating in the Saudi market since 2017. This was marked by the establishment of the Amgen Scientific Office in Riyadh. In 2020, (Amgen Saudi Arabia Limited) transformed into a fully-fledged company after obtaining a foreign investment license.

Since its inception, Amgen has been committed to achieving sustainable development of the healthcare level to build a healthier and more prosperous society and to continue providing innovative human therapeutics to patients in the Kingdom of Saudi Arabia in line with Vision 2030.

Our mission is to serve patients by helping them live longer and fuller lives, and we do so by harnessing the best of biology and technology.

More than 40 Years Presence in Kingdom of Saudi Arabia

Johnson & Johnson (J&J) has been serving the healthcare needs of Saudi Arabia for more than 40 years, initially partnering with local distributors.

Strategic Shift to align with Vision 2030

In 2017, J&J established a Joint Venture for Medical Technology (MedTech) and a Scientific Office for Pharmaceuticals, marking a new phase of direct involvement. Saudi Arabia emerged as an attractive market for us to strengthen our presence and meet the increasing demand of patients and healthcare professionals. Our growth plans are aligned with the Vision 2030 reforms that prioritize economic growth, particularly in the healthcare sector.

Commitment to Growth

In 2023, we established a wholly-owned commercial and legal entity for our Pharmaceuticals division and attained full ownership for the joint venture that supports our MedTech division. Our investments not only demonstrate our commitment to the Kingdom but also support a range of activities that contribute significantly to the healthcare sector and overall economy of Saudi Arabia.

Our Purpose

We blend heart, science, and ingenuity to profoundly impact health for humanity. We aspire to develop breakthrough treatments to transform the future of health, discovering new pathways and potential cures.

Drawing on our legacy of working alongside clinicians, we are focused on solving the world’s most pressing healthcare challenges through innovations at the intersection of biology and technology.

DaVita entered the Kingdom of Saudi Arabia in 2014 in partnership with the Ministry of Health, to provide world-class kidney care for Saudi patients.

Working together for the past 10 years, DaVita and the Ministry of Health’s relationship is among the strongest examples of public / private healthcare partnership in the world. DaVita strives to improve the quality of life for people with kidney failure, delivering a differentiated care experience for our patients across our 25 treatment clinics in urban and regional areas of the Kingdom. Through our 30 years of experience in the United States and our unique culture we define as The DaVita Way, DaVita is improving clinical outcomes for kidney patients around the world and positively contributing to the national healthcare systems which support them.

At MSD, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.

MSD products have been present for over 30 years in the GCC region through local distributors in the UAE, KSA, Kuwait, Bahrain, Qatar & Oman.